AngioDynamics is a debt-free med-tech turnaround with high-growth vascular and oncology platforms that could re-rate meaningfully if execution converts innovation into durable profitability.
Overview
AngioDynamics is a U.S.-centric medical technology company focused on vascular flow restoration, thrombectomy, and oncology ablation. Its Med Tech segment—Auryon, AlphaVac/AngioVac, and NanoKnife—is the strategic growth engine, while legacy Med Device products provide stability and cash generation. The investment case centers on accelerating high-margin, recurring procedure-based revenue, especially as NanoKnife gains prostate cancer reimbursement support and Auryon/AlphaVac expand adoption in differentiated clinical niches.